Table 2. Experimental and predicted activity of training set compounds based on Hypo 1.
| Compound No | Fit value | Experimental IC50 (nmol/L) | Predicted IC50 (nmol/L) | Errora | Experimental scaleb | Predicted scaleb |
|---|---|---|---|---|---|---|
| 1 | 7.89 | 4.7 | 9.1 | +1.9 | +++ | +++ |
| 2 | 7.86 | 6.8 | 9.9 | +1.5 | +++ | +++ |
| 3 | 7.81 | 7.6 | 11 | +1.5 | +++ | +++ |
| 4 | 7.88 | 8.6 | 9.5 | +1.1 | +++ | +++ |
| 5 | 7.96 | 8.8 | 7.9 | −1.1 | +++ | +++ |
| 6 | 7.83 | 9.7 | 10 | +1.1 | +++ | +++ |
| 7 | 7.79 | 12 | 11 | −1.1 | +++ | +++ |
| 8 | 7.01 | 69 | 70 | +1.0 | +++ | +++ |
| 9 | 7.09 | 80 | 57 | −1.4 | +++ | +++ |
| 10 | 6.86 | 130 | 98 | −1.3 | ++ | +++ |
| 11 | 6.06 | 280 | 610 | +2.2 | ++ | ++ |
| 12 | 5.94 | 480 | 820 | +1.7 | ++ | ++ |
| 13 | 6.26 | 620 | 390 | −1.6 | ++ | ++ |
| 14 | 5.91 | 850 | 870 | +1.0 | ++ | ++ |
| 15 | 5.74 | 1400 | 1300 | −1.1 | ++ | ++ |
| 16 | 5.58 | 2900 | 1900 | −1.6 | ++ | ++ |
| 17 | 5.41 | 4000 | 2800 | −1.4 | ++ | ++ |
| 18 | 5.7 | 6100 | 1400 | −4.2 | ++ | ++ |
| 19 | 4.01 | 9600 | 70000 | +7.3 | ++ | + |
| 20 | 4.37 | 16000 | 31000 | +1.9 | + | + |
| 21 | 4.37 | 37000 | 30000 | −1.2 | + | + |
| 22 | 4.25 | 46000 | 40000 | −1.2 | + | + |
| 23 | 4.33 | 63000 | 34000 | −1.9 | + | + |
| 24 | 4.35 | 90000 | 32000 | −2.8 | + | + |
a Error, ratio of the predicted activity (Pred IC50) to the experimental activity (Exp IC50) or its negative inverse if the ratio is <1.
b Activity scale: IC50<100 nmol/L=+++ (active), 100 nmol/L≤IC50<10000 nmol/L=++ (moderate active), IC50≥10000 nmol/L=+ (inactive).